Author:
Yang Jung-min,Jang Kwon-jun,Ko Eun-bi,Lee Ji-yoon,Yoon Min-ji,Jo On-you,Jeong Seong-heon,Moon Hyang-ran,Shin Kwang-soon,Hwang Woo-seok
Abstract
Objectives: This study examined the case of a patient with recurrent salivary duct carcinoma and hepatic metastasis.Methods: The patient was treated with Casodex/Nolvadex from January 25<sup>th</sup> 2021 onward with doses of bicalutamide (150 mg/day) and tamoxifen (10 mg/day) every four weeks. Simultaneously, the patient was treated with Korean medicine. The tumor size was measured using computed tomography (CT). Adverse events were evaluated according to the National Cancer Institute’s Common Terminology Criteria for Adverse Events (NCI-CTCAE), version 5.0.Results: Following the four-month treatment, the extent of the proximal portion of hepatic metastasis decreased, and discomfort and physical activity gradually improved.Conclusions: The results suggest that combined chemotherapy and Korean medicine may help to reduce tumor size and improve quality of life.
Publisher
The Society of Internal Korean Medicine
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献